TCRRUnknown
TCR2 THERAPEUTICS INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for TCR2 THERAPEUTICS INC. (TCRR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are TCRR insiders buying or selling?
TCR2 THERAPEUTICS INC. insiders reported no open-market purchases or sales in the last 12 months. Since February 2019, Trabud has recorded 39 Form 4 filings for TCRR: 10 buys ($65.7M) and 29 sells ($16.8M).
Source: SEC EDGAR Form 4
Key Statistics (February 2019 – May 31, 2023)
Total Form 4 filings
39
SEC EDGAR
Insider filers
16
Insider buys (10)
$65.7M
Insider sells (29)
$16.8M
Insider sentiment
Net buyingNet insider flow of $48.9M in net buying since February 2019.
Recent TCRR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2023 | Kevin C Tang | 10% Owner | Purchase | 50.0K | $1.72 | $86.0K | SEC ↗ |
| May 24, 2023 | MPM ASSET MANAGEMENT LLC | 10% Owner | Sale | 70.2K | $1.88 | $131.9K | SEC ↗ |
| May 24, 2023 | Ansbert Gadicke | Director, 10% Owner | Sale | 70.2K | $1.88 | $131.9K | SEC ↗ |
| May 15, 2023 | Kevin C Tang | 10% Owner | Purchase | 44.9K | $1.95 | $87.6K | SEC ↗ |
| May 10, 2023 | Kevin C Tang | 10% Owner | Purchase | 84.0K | $1.95 | $163.8K | SEC ↗ |
| May 5, 2023 | Kevin C Tang | 10% Owner | Purchase | 289.6K | $1.89 | $547.9K | SEC ↗ |
| Dec 14, 2022 | Alfonso Quintas Cardama | Chief Medical Officer | Sale | 13.8K | $1.10 | $15.1K | SEC ↗ |
| Dec 14, 2022 | Peter Olagunju | Chief Technical Officer | Sale | 4.8K | $1.10 | $5.3K | SEC ↗ |
| Dec 14, 2022 | Angela Justice | Chief People Officer | Sale | 8.6K | $1.10 | $9.4K | SEC ↗ |
| Dec 14, 2022 | Garry E Menzel | President and CEO | Sale | 31.9K | $1.10 | $35.0K | SEC ↗ |
| Dec 9, 2022 | Alfonso Quintas Cardama | Chief Medical Officer | Sale | 7.9K | $1.27 | $10.1K | SEC ↗ |
| Dec 9, 2022 | Garry E Menzel | President and CEO | Sale | 18.4K | $1.27 | $23.4K | SEC ↗ |
| Dec 9, 2022 | Angela Justice | Chief People Officer | Sale | 5.0K | $1.27 | $6.3K | SEC ↗ |
| Dec 9, 2022 | Peter Olagunju | Chief Technical Officer | Sale | 2.8K | $1.27 | $3.5K | SEC ↗ |
| Dec 8, 2022 | Alfonso Quintas Cardama | Chief Medical Officer | Sale | 7.5K | $1.35 | $10.1K | SEC ↗ |
| Dec 8, 2022 | Peter Olagunju | Chief Technical Officer | Sale | 2.6K | $1.35 | $3.5K | SEC ↗ |
| Dec 8, 2022 | Garry E Menzel | President and CEO | Sale | 23.4K | $1.36 | $31.8K | SEC ↗ |
| Dec 8, 2022 | Angela Justice | Chief People Officer | Sale | 4.7K | $1.35 | $6.3K | SEC ↗ |
| Dec 6, 2022 | Alfonso Quintas Cardama | Chief Medical Officer | Sale | 3.6K | $1.39 | $5.1K | SEC ↗ |
| Dec 6, 2022 | Peter Olagunju | Chief Technical Officer | Sale | 1.3K | $1.39 | $1.8K | SEC ↗ |
| Dec 6, 2022 | Garry E Menzel | President & CEO | Sale | 8.4K | $1.39 | $11.7K | SEC ↗ |
| Dec 6, 2022 | Angela Justice | Chief People Officer | Sale | 2.3K | $1.39 | $3.2K | SEC ↗ |
| Dec 16, 2020 | Mayur Ian Somaiya | Chief Financial Officer | Sale | 2.0K | $35.00 | $70.0K | SEC ↗ |
| Nov 19, 2020 | Mayur Ian Somaiya | Chief Financial Officer | Sale | 3.7K | $30.00 | $110.0K | SEC ↗ |
| Nov 13, 2020 | Robert Hofmeister | Chief Scientific Officer | Sale | 20.0K | $25.10 | $502.0K | SEC ↗ |
Showing the 25 most recent of 39 Form 4 filings for TCR2 THERAPEUTICS INC..
Most active TCRR insiders
- Morana Jovan-Embiricos6 filings
- Alfonso Quintas Cardama4 filings
- Angela Justice4 filings
- Garry E Menzel4 filings
- Kevin C Tang4 filings
Ask anything about TCRR insider activity
Use Trabud's AI agent to query TCR2 THERAPEUTICS INC.'s Form 4 history in plain English — "Show me TCRR CEO purchases this year" or compare it against any other ticker.
Open the AI agentTCRR insider trading FAQ
Are TCR2 THERAPEUTICS INC. insiders buying or selling?
TCR2 THERAPEUTICS INC. insiders reported no open-market purchases or sales in the last 12 months. Since February 2019, Trabud has recorded 39 Form 4 filings for TCRR: 10 buys ($65.7M) and 29 sells ($16.8M). Over the full record that is net buying of $48.9M.
How many insiders trade TCRR stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TCR2 THERAPEUTICS INC.. The most recent filing was accepted on May 31, 2023.
Where does Trabud get TCRR insider trading data?
All TCRR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.